New dimensions in the pharmacologic treatment of schizophrenia and related psychoses

Peter F Buckley

Research output: Contribution to journalReview article

21 Scopus citations

Abstract

During the past 5 years unprecedented advances have taken place in the psychopharmacology of schizophrenia and related psychoses. Clozapine and risperidone, two prototypic novel antipsychotic drugs, have had a significant impact on the treatment of psychotic disorders. Additionally, they have ushered in another generation of antipsychotic drugs with complex pharmacologic profiles, potentially enhanced efficacy, and more benign side- effect profiles than previously associated with conventional antipsychotic medications. This review highlights these developments, implications for the management of psychotic disorders, and the use of novel antipsychotic drugs in specific clinical subgroups.

Original languageEnglish (US)
Pages (from-to)363-378
Number of pages16
JournalJournal of Clinical Pharmacology
Volume37
Issue number5
DOIs
StatePublished - Jan 1 1997

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'New dimensions in the pharmacologic treatment of schizophrenia and related psychoses'. Together they form a unique fingerprint.

  • Cite this